Lunai Bioworks

New York, United States

Lunai Bioworks is a biotechnology business committed to developing enhanced allogenic cell and gene therapies.

$20.0M raised

Apr 2026

Post-IPO Equity

Biotechnology Health Care Medical Device

Top Investors

Clemann Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lunai Bioworks

How much funding has Lunai Bioworks raised?

Lunai Bioworks has raised $20.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Who are Lunai Bioworks's investors?

Lunai Bioworks's investors include Clemann Group.

Where is Lunai Bioworks headquartered?

Lunai Bioworks is headquartered in New York, United States.

What does Lunai Bioworks do?

Lunai Bioworks is a biotechnology business committed to developing enhanced allogenic cell and gene therapies.

What stage is Lunai Bioworks at?

Lunai Bioworks is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 15, 2026.

MLA

"Lunai Bioworks — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/lunai-bioworks. Accessed July 2, 2026.

APA

VCBacked. (2026). Lunai Bioworks — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lunai-bioworks

Wikipedia (cite web)

{{cite web |title=Lunai Bioworks — Funding & Investors |url=https://www.vcbacked.co/company/lunai-bioworks |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 15, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K